GRI Bio, Inc. - Common Stock (GRI)
1.4000
+0.00 (0.00%)
NASDAQ · Last Trade: Apr 8th, 9:05 AM EDT
GRI Bio reported interim Phase 2a results for GRI-0621 in IPF, showing safety and no significant cholesterol changes.
Via Benzinga · April 1, 2025

Via Benzinga · November 15, 2024

Via Benzinga · November 1, 2024

GRI Bio just reported results for the second quarter of 2024.
Via InvestorPlace · August 14, 2024

GRI Bio just reported results for the first quarter of 2024.
Via InvestorPlace · May 13, 2024

Via Benzinga · October 23, 2024

Via Benzinga · October 22, 2024

Via Benzinga · October 22, 2024

Via Benzinga · October 22, 2024

Via Benzinga · October 21, 2024

Via Benzinga · October 21, 2024

Via Benzinga · October 21, 2024

Via Benzinga · October 18, 2024

Via Benzinga · October 14, 2024

Via Benzinga · October 8, 2024

Via Benzinga · October 8, 2024

Via Benzinga · September 30, 2024

Biotech stocks can be extremely challenging because it takes a long time to bring a therapy to market. Here are some biotech stocks to sell.
Via InvestorPlace · July 22, 2024

Pre-market stock movers are worth diving into this morning and we have all of the hottest news worth checking out on Thursday!
Via InvestorPlace · July 18, 2024

Taysha Gene Therapies stock is down on Wednesday after the company announced a proposed public offering for TSHA shares.
Via InvestorPlace · June 26, 2024

GRI Bio stock is down on Wednesday after the company announced a proposed public offering for some 2 million GRI shares.
Via InvestorPlace · June 26, 2024

It's time to dive into the biggest pre-market stock movers as we check out all of the latest news happening on Wednesday morning!
Via InvestorPlace · June 26, 2024

It's time to dive into the biggest pre-market stock movers as we check out all of the hottest news on Monday morning!
Via InvestorPlace · June 24, 2024